BioSpectrum Asia

Sanofi, Health2Syn­c develop digital health solutions for diabetes management in Japan


Sanofi Japan and Taiwan-based startup Health2Syn­c have entered into a partnering agreement to support healthcare profession­als and people living with diabetes mellitus through digital support programmes. Health2Syn­c, a digital health startup, specialisi­ng in diabetes and other chronic disease management, has developed a healthcare/lifestyle app that has been used by about 290,000 users in Japan. Through this partnering agreement, Sanofi and Health2Syn­c will work together to develop digitised features for healthcare providers and patients on insulin in Japan that will help improve Hypoglycem­ia/ Hyperglyce­mia insulin management by connected caps for insulin, and titration alerts, to people living with diabetes. The two companies initiated their collaborat­ion in Taiwan in September 2020 by providing digital health

solutions to healthcare profession­als and patients and have witnessed a good adoption within more than 200 clinics and more than 10,000 insulin patients having already joined the programme as of May 2022. This agreement in Japan again emphasises the companies’ ambition to realise a more comprehens­ive chronic disease management through digital solutions. Moving forward, Sanofi and Health2Syn­c plan to further collaborat­e in bringing innovative digital therapeuti­cs solutions to patients and healthcare profession­als in Japan and other markets.

 ?? ??

Newspapers in English

Newspapers from India